Literature DB >> 32150273

Health service costs and their association with functional impairment among adults receiving integrated mental health care in five low- and middle-income countries: the PRIME cohort study.

Dan Chisholm1, Emily Garman2, Erica Breuer2, Abebaw Fekadu3, Charlotte Hanlon3,4, Mark Jordans3, Tasneem Kathree5, Fred Kigozi6, Nagendra Luitel7, Girmay Medhin4, Vaibhav Murhar8, Inge Petersen5, Sujit D Rathod9, Rahul Shidhaye10, Joshua Ssebunnya6, Vikram Patel10,11, Crick Lund2,3.   

Abstract

This study examines the level and distribution of service costs-and their association with functional impairment at baseline and over time-for persons with mental disorder receiving integrated primary mental health care. The study was conducted over a 12-month follow-up period in five low- and middle-income countries participating in the Programme for Improving Mental health carE study (Ethiopia, India, Nepal, South Africa and Uganda). Data were drawn from a multi-country intervention cohort study, made up of adults identified by primary care providers as having alcohol use disorders, depression, psychosis and, in the three low-income countries, epilepsy. Health service, travel and time costs, including any out-of-pocket (OOP) expenditures by households, were calculated (in US dollars for the year 2015) and assessed at baseline as well as prospectively using linear regression for their association with functional impairment. Cohort samples were characterized by low levels of educational attainment (Ethiopia and Uganda) and/or high levels of unemployment (Nepal, South Africa and Uganda). Total health service costs per case for the 3 months preceding baseline assessment averaged more than US$20 in South Africa, $10 in Nepal and US$3-7 in Ethiopia, India and Uganda; OOP expenditures ranged from $2 per case in India to $16 in Ethiopia. Higher service costs and OOP expenditure were found to be associated with greater functional impairment in all five sites, but differences only reached statistical significance in Ethiopia and India for service costs and India and Uganda for OOP expenditure. At the 12-month assessment, following initiation of treatment, service costs and OOP expenditure were found to be lower in Ethiopia, South Africa and Uganda, but higher in India and Nepal. There was a pattern of greater reduction in service costs and OOP spending for those whose functional status had improved in all five sites, but this was only statistically significant in Nepal. © World Health Organization 2020. All rights reserved. The World Health Organization has granted the Publisher permission for the reproduction of this article.

Entities:  

Keywords:  Mental health care; low- and middle-income countries; service costs

Mesh:

Year:  2020        PMID: 32150273     DOI: 10.1093/heapol/czz182

Source DB:  PubMed          Journal:  Health Policy Plan        ISSN: 0268-1080            Impact factor:   3.344


  4 in total

1.  Efficacy and cost-effectiveness of task-shared care for people with severe mental disorders in Ethiopia (TaSCS): a single-blind, randomised, controlled, phase 3 non-inferiority trial.

Authors:  Charlotte Hanlon; Girmay Medhin; Michael E Dewey; Martin Prince; Esubalew Assefa; Teshome Shibre; Dawit A Ejigu; Hanna Negussie; Sewit Timothewos; Marguerite Schneider; Graham Thornicroft; Lawrence Wissow; Ezra Susser; Crick Lund; Abebaw Fekadu; Atalay Alem
Journal:  Lancet Psychiatry       Date:  2022-01       Impact factor: 27.083

Review 2.  A Systematic Review of Culturally Responsive Approaches to Child and Adolescent Mental Health Care in Ethiopia.

Authors:  Hana Shewamoltot Meshesha; Veronica Johnson
Journal:  Front Sociol       Date:  2021-02-02

3.  Scaling up mental health care and psychosocial support in low-resource settings: a roadmap to impact.

Authors:  Mark J D Jordans; Brandon A Kohrt
Journal:  Epidemiol Psychiatr Sci       Date:  2020-11-26       Impact factor: 6.892

Review 4.  WHO mental health gap action programme (mhGAP) intervention guide: updated systematic review on evidence and impact.

Authors:  Roxanne Keynejad; Jessica Spagnolo; Graham Thornicroft
Journal:  Evid Based Ment Health       Date:  2021-04-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.